ARCHIVES

In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs

This article is from The Cancer Letter archive.

Vol. 18 No. 03 | January 17, 1992

Download PDF Visit The Full Archive

Related Articles

Cancer Groups Fear Clinical Trials Coverage Will Not Be Implemented Across Exchanges

July 3, 2013

NCCN Guidelines Retain Avastin For Breast Cancer

October 22, 2010

Tissue of Origin Test Consistent With Diagnosis In Blinded Validation Study

January 28, 2011

Nobel In Chemistry For Work Linking Carbon Atoms

October 8, 2010

In Brief: Fred Hutchinson Center celebrates Massive Move Of 36 Labs, 400 Employees to New Campus

June 25, 1993

More Than 3,000 Letters If Intent Sent To army For Breast Programs

September 10, 1993